Company Profile
Theravance Biopharma Stock Price, News & Analysis
- Ticker:
- TBPH
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Theravance Biopharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
16.97 USD (+2.48%)
Close
Last updated: June 23, 2026 at 00:00
874.85M USD
Market cap
Why the stock is moving
TBPH is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Theravance Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Theravance Biopharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Theravance Biopharma follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Theravance Biopharma sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
Source: Theravance Biopharma
- 02
Theravance Biopharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Source: Theravance Biopharma
- 03
- 04
- 05
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
Source: Theravance Biopharma
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Theravance Biopharma (TBPH)?
Theravance Biopharma (TBPH) most recently closed at 16.97 USD, a +2.48% move versus the previous session.
What is the market cap of Theravance Biopharma (TBPH)?
Theravance Biopharma currently has a market capitalization of 874.85M USD on BioPharmSignal.
What does Theravance Biopharma do?
Theravance Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is TBPH stock listed?
Theravance Biopharma (TBPH) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Theravance Biopharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Theravance?
Theravance Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Theravance Biopharma targeting with Theravance?
Theravance Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biopharma?
Theravance Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.